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Abstract
Background: This study aims to evaluate relationship between three different clinical conditions: Major Depressive
Disorders (MDD), Hashimoto Thyroiditis (HT) and reduction in regional Cerebral Blood Flow (rCBF) in order to
explore the possibility that patients with HT and MDD have specific pattern(s) of cerebral perfusion.
Methods: Design: Analysis of data derived from two separate data banks.
Sample: 54 subjects, 32 with HT (29 women, mean age 38.8 ± 13.9); 22 without HT (19 women, mean age 36.5 ±
12.25).
Assessment: Psychiatric diagnosis was carried out by Simplified Composite International Diagnostic Interview (CIDIS)
using DSM-IV categories; cerebral perfusion was measured by
99 mTc-ECD SPECT. Statistical analysis was done
through logistic regression.
Results: MDD appears to be associated with left frontal hypoperfusion, left temporal hypoperfusion, diffuse
hypoperfusion and parietal perfusion asymmetry. A statistically significant association between parietal perfusion
asymmetry and MDD was found only in the HT group.
Conclusion: In HT, MDD is characterized by a parietal flow asymmetry. However, the specificity of rCBF in MDD
with HT should be confirmed in a control sample with consideration for other health conditions. Moreover, this
should be investigated with a longitudinally designed study in order to determine a possible pathogenic cause.
Future studies with a much larger sample size should clarify whether a particular perfusion pattern is associated
with a specific course or symptom cluster of MDD.
Background
Hashimoto Thyroiditis [HT] is a chronic organ-specific
autoimmune disorder commonly observed in clinical
practice and is frequently associated with mood disor-
ders [1-3]. In patients with HT, a form of encephalopa-
thy known as Hashimoto Encephalopathy (HE) has been
described as a severe but rare syndrome with different
clinical presentations and course [4]. Presentation of
such a syndrome may include alteration of conscious
level, seizures, tremor, myoclonus, ataxia, or multiple
stroke-like episodes. Psychiatric symptoms, including
depression and psychosis, have also been reported [5]. A
manic episode associated with HT, pathological EEG
and response to short-term treatment with high doses
of prednisolone, has been reported as the first case of
bipolar disorder due to HE [6].
The aetiopathogenesis of HE is not yet well defined.
This form of encephalopathy is understood to be inde-
pendent from thyroid function since patients can pre-
sent with variable clinical pictures from frank
hypothyroidism to hyperthyroidism, but subclinical
hypothyroidism is more frequent [7]. However, indepen-
dent of these rare cases of HE, several observations indi-
cate that there is a frequent decrease in cerebral
perfusion in patients with autoimmune thyroiditis. This
suggests cerebral vasculitis as a possible pathogenic
model or cause [8,9].
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reduced cerebral perfusion with SPECT in patients suf-
fering from HT. This study did not show any specific
topographic pattern of hypoperfusion with SPECT-VOI
based analysis, however, it did show that the left poster-
ior gyrus of the cingulate region was most affected.
Another study by Piga et al. [9] showed a high preva-
lence of mild, yet significant perfusion anomalies in cer-
ebral cortex of HT patients with euthyroidism, however,
this was not observed in patients with non-toxic multi-
nodular goitre. These perfusion anomalies are qualita-
tively similar to those observed in sporadic cases of
severe HE. This survey additionally found a frontal per-
fusion asymmetry in patients with HT compared to
patients with non-toxic multinodular goitre.
The use of functional imaging methods for studying
psychiatric disorders have aroused a great deal of inter-
est over the past few years, both for clinical (diagnostic
and therapeutic) and research purposes [10-12]. These
studies showed that in patients with depression, ventral
frontal and prefrontal regions had an increase in meta-
bolism or perfusion, whereas more rostral regions within
the cingulate gyrus and dorsolateral prefrontal cortex
had a decrease in perfusion/metabolism [13-19].
Recently Bocchetta et al. [20] described a case of affec-
tive psychosis with HT and brain perfusion abnormal-
ities. They hypothesized that abnormalities in cortical
perfusion might represent a pathogenic link between
HT and mood disorders, even in the absence of other
prominent symptoms of CNS inflammation or EEG
abnormalities. Therefore, the rare severe cases of HE
presenting with mood disorders may represent only the
tip of an iceberg.
Considering the possibility of an association between
depressive disorders and HT and the association
between decreases in rCBF and depressive disorders,
the hypothesis that the three conditions (decreases in
specific regional blood flow, MDD and HT) might be
interrelated is of great interest. This is particularly so
if cerebrovascular damage can be invoked in the
pathogenesis of psychiatric disorders, such as depres-
sion, given that these are often associated with
thyroiditis.
In this paper, we evaluated data from\data banks of
cerebral perfusion measured using SPECT with
99 mTc
etil-cysteinate dimer (ECD) in HT patients with and
without any mood disorders, celiac disease with and
without mood disorders, and non-toxic nodular goitre
with and without mood disorders. While the data bank
was not specifically built to investigate correlation
between cerebral perfusion, MDD and HT, with appro-
priate statistical tools to correct confounding factors, we
sought to identify correlation, if any, at least from a pre-
liminary heuristic perspective.
Methods
Study design
The study adopted a cross sectional observational
design. We compared cerebral perfusion through a mul-
tivariate data analysis technique in a group of patients
with a large proportion affected by HT.
The study made use of collection of data from two
separate databases; the data represents investigation of
cerebral perfusion and psychiatric disorders in patients
with thyroiditis (versus endemic goitre) and in subjects
with coeliac disease (with and without thyroiditis). For
this reason a significant number of subjects among
patients (with HT) and controls (without HT) were
affected by coeliac disease; this condition is extremely
frequent in HT (Odds Ratio from 5 to 15 in various stu-
dies) [21], and will be treated as a confounding variable
as per the multivariate data analysis technique.
Patients and control subjects with Coeliac Disease
undertook a gluten free diet for at least six months. The
duration of symptoms of their coeliac disease varied
from 6 months to 52 years, with a mean duration of 14
years (mean ± SD = 14.0 ± 8.3).
Control subjects not affected by coeliac disease had
endemic goitre (NTMG), a thyroid condition not depen-
dent on autommunity and were in euthymic state.
Sample
The study population included 4 subgroups, all recruited
from among inpatients at the University Hospital “Poli-
clinico di Monserrato” of Cagliari; stratification by age
implied a subdivision of patients of each subgroup into
four age groups: 18-24, 25-44, 45-64 and > 65 years
(Table 1).
￿ Subgroup A cases: 16 adults, all female, affected by
HT with euthyroidism, aged from 24 to 62 years (mean
± SD = 36.6 ± 10.9).
￿ Subgroup B, cases with celiac disease: 16 adults
affected by coeliac disease and HT with euthyroidism;
Table 1 The study sample
Subgroup
A
HT
Subgroup B
HT and
Coel.
Subgroup
D
NTM
(No HT)
Subgroup
C
Coel.
(No HT)
N 16 16 6 16
N. Female 16 13 6 13
Mean Age ±
sd
36.6 ± 10.9 43.1 ± 16.1 38 ± 12.5 35.9 ± 12.5
Age 18 - 24 1111
Age 25 - 44 11 7 2 12
Age 45 - 64 4633
Age > 65 0200
HT = Hashimoto Thyroiditis; Coel. = Coeliac Disease; TMG: Non-Toxic
Multinodular Goitre.
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16.1).
￿ Subgroup C, controls: 6 adults with non-toxic nodu-
lar goitre (NTNG). All were female, age ranged from 24
to 51 years (38 ± 12.5).
￿ Subgroup D, controls with celiac disease: 16 adult
coeliac patients without HT. Includes 13 women and 3
men, age ranged from 20 to 64 years (35.9 ± 12.5); they
are age- and gender-matched with coeliac patients with
HT (group B).
Endocrinological Diagnosis:Thyroid function tests and
ultrasound
The diagnosis of HT with euthyroidism was made on
the basis of coexistence of high titres of antithyroid
autoantibody (AbTPO), a marked and diffuse ultrasono-
graphic hypoechogenicity of the thyroid gland and nor-
mal concentration of free thyroid hormones and
Thyrotropin Stimulating Hormone (TSH).
The diagnosis of non-toxic multinodular goitre
(NTMG) was based on ultrasound evidence of one or
more thyroid nodules in a normoechogenic gland, along
with the absence of antithyroid autoantibodies and nor-
mal levels of free thyroid hormones and TSH.
The serum concentration of TSH was measured by
chemiluminescence (Ortho-Clinical Diagnostic, Amer-
sham, U.K.) with normal levels ranging from 0.3 to 3
mU/L. Free triiodothyronine (fT3) and thyroxine (fT4)
were measured by means of chromatographic method
based on the separation of fT4 on Lisophase columns
(Technogenetics, Milan, Italy); normal values: fT4: 6.6-
1.6 pg/ml; fT3: 2.8-5.6 pg/ml). Antimicrosomal autoanti-
bodies (anti-M) and antithyroglobulin (anti-Tg) were
determined through passive agglutination (SERODIA-
AMC e SERODIA-ATG; Fujirebio Inc. Pharmaceutical,
Tokyo, Japan). The thyroid ultrasound was performed
using a “real-time” echograph (ALOKA Mod SSd 500
with a 7,5 Mhz sound). The volumetric levels evaluated
with this test were included for all the patients in the
study. Given the wide variability of the data, the mean
of volumes was calculated and values differing more
than 2 standard deviations (SD) were considered
abnormal.
Diagnosis of Coeliac Disease
The diagnosis of coeliac disease in group B and in the
control group C was done using the IgA anti-endomy-
sial antibodies (EMA), IgA anti-gliadin antibodies
(AGA-A) and small intestine biopsy. EMA were deter-
mined by an indirect immunofluorescence method using
monkey oesophagus as substrate and titres of ≥ 1:5 were
considered positive. AGA-A was measured with an
enzyme-linked immunosorbent assay (ELISA) (Phadia
Diagnostic, Uppsala, Sweden) with a 10 IU/ml value as
the lower positive limit. Biopsy specimens (minimum
four) obtained from the distal part of the duodenum,
were classified according to the modified Marsh criteria
[22]. Specimens were classified as type 0 (normal small
bowel mucosa), type 1 (> 40 intra-epithelial lymphocytes
[IELs] per 100 enterocytes but without other stigmata of
gluten enteropathy), type 3A (mild villous flattening,
increase in crypt height, increase in IEL numbers up to
> 40 IEL/100 enterocytes), type 3B (marked villous flat-
tening, increase in crypt height, increase in IEL numbers
up to > 40 IEL/100 enterocytes) and type 3C (total vil-
lous flattening, increase in crypt height, increase in IEL
numbers up to > 40 IEL/100 enterocytes)
Psychiatric Diagnosis
The lifetime psychiatric diagnosis was formulated by
physicians using the simplified Italian version of the
structured interview CIDIS [23] according to DSM-IV
criteria [24]. This tool is the simplified version of CIDI
(Composite International Diagnostic Interview) [25].
The CIDIS was administered to all patients soon after
their recruitment to the study. The module for the sim-
plified interview CIDIS consists in a total of 105 ques-
tions. The interview was done for 45 minutes to about
two hours. The presence, duration and severity of symp-
toms for the various groups were determined.
Collected data were elaborated by a specific computer
program, which formulates all the diagnoses according
to the Diagnostic and Statistical Manual by the Ameri-
can Psychiatric Association DSM-IV TR [24]. Diagnoses
are formulated on a lifetime basis, but it is also possible
to relate the diagnosis to four different periods: one
week, one month, six months, and one year,
respectively.
Lifetime diagnosis considered for this study
For the purpose of this study the following specific diag-
noses were considered: Major Depressive Disorder
(MDD), Panic Disorder (PD), and Generalized Anxiety
Disorder (GAD).
Cerebral Perfusion-SPECT
In order to obtain a bound fraction superior to 90%,
99
mTc etil-cysteinate dimer (ECD) was prepared according
to the instructions included in Neurolite kit packaging
(Du Pont Pharma, Italy). After 15 minutes from posi-
tioning an infusion catether in a forearm vein, with the
patient in supine position, with open eyes, and in the
absence of any environmental stimuli, intravenous
administration of
99 mT c - E C Da tad o s eo f7 4 0M B q
was done. The patient’s head was immobilized to avoid
any head movements. The cerebral SPECT was carried
out after 30 minutes using a double head gamma cam-
era (Varicam- Elscint-Israel) provided with very high
resolution collimators. Rotation radius was 13 cm. An
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1.0 was used. Data were acquired through 120 scans
during 30 sec, each performed at intervals of 3 degrees
for a total of 360°. Total time of acquisition was 30 min-
utes. Images were reconstructed through filtered retro-
projections using a Butterworth filter type and a Chang
attenuation correction of 0.1/cm
-1.I m a g e sw e r ee v a l u -
ated by two nuclear medicine physicians with expertise
in the interpretation of cerebral perfusion SPECT. The
evaluation of images was both qualitative and semiquan-
titative. On visual analysis, anomalies in cerebral areas
where the uptake of the radioactive drug was decreased
in at least three consecutive images, were considered
pathological. The semiquantitative analysis in order to
evaluate the asymmetries in cortical perfusion was per-
formed through the definition of 3 predetermined
regions of interest (ROIs) for each cerebral hemisphere:
frontal (F), temporal (T) and parietal (P). The percen-
tage values of asymmetry (Asymmetry Index = AI) were
calculated bilaterally for the ROIs to allow the measure-
ment of both the degree and the direction of perfusional
asymmetry [26]. The determination of AI was made
according the following formula: [(R-L)/(R+L) × 0, 5] ×
100; whereas R = numeric quantitative data of right ROI
and L = numeric quantitative data of left ROI. An AI ±
5% was considered as normal.
Informed, signed consent was obtained from every
patient undergoing SPECT.
Statistical Analyses
Values for continuous data are expressed as mean ± SD.
Statistical analyses were carried out in two subsequent
steps following a logistic regression approach. In both
steps, MDD was considered as dependent variable and
all possible risk factors as independent variables.
First, all possible risk factors were entered simulta-
neously in a single block. For each predictor, a P - value
less than 0.05 was considered statistically significant.
Second, all two-way interactions between the possible
risk factors were added. To select significant interac-
tions, a backward elimination procedure with a thresh-
old of P < 0.20 was used.
Ethical Aspects
The two studies generating the two data banks from
which the data were drawn were approved by the ethical
committee of the Policlinico Universitario di Cagliari.
Each subject in the study was identifiable with a code
number. An informed consent for the use of anonymous
data for scientific purposes was obtained from each
patient. The link between the code number and the
name of the patient was not available for the research-
ers. The present study was approved by the ethical com-
mittee of the Reald University.
Results
In Table 2, the frequency, expressed as percentage, of a
specific psychiatric diagnosis (MDD, PD and GAD) and
at least one psychiatric diagnosis among all the patients
(4 sub groups) are shown. No statistically significant dif-
ferences were detected in the frequency of a specific
psychiatric disorder and patients with at least one psy-
chiatric diagnosis in the 4 sub-groups.
Perfusion anomalies in relation to MDD are shown in
Table 3. In particular, SPECT Left Frontal hypoperfu-
sion, SPECT Parietal Perfusion Asymmetry, SPECT dif-
fuse hypoperfusion and SPECT Left Temporal showed a
significant effect at P < 0.05.
In two-way interactions between all possible risk fac-
tors, only the interaction between left temporal hypoper-
fusion and HT reached a statistical significance (p =
0.16; O.R. = 0.07): the presence of HT decreased the sig-
nificance of left temporal hypoperfusion on MDD.
Table 2 Association between Psychiatric Diagnoses and
Subgroups
Subgroup
A
HT
Subgroup
B
HT and
Coel.
Subgroup
C
NTMG
Subgroup
D
Coel.
P
MDD 37.5%
(6)
18.75%
(3)
16.67%
(1)
25%
(4)
0.71
GAD 37.5%
(6)
37.5%
(6)
33.33%
(2)
12.5%
(2)
0.34
PD 12.5%
(2)
18.75%
(3)
0%
(0)
12.5%
(2)
0.94
At least
one
Psychiatric
Diagnosis
62.5%
(10)
62.5%
(10)
33.33%
(2)
56.25%
(9)
0.71
Observed frequencies are in parentheses. Given that each test was conducted
on tables larger than 2 × 2, and because most cells had small counts, Fisher’s
exact test was used.
Table 3 Perfusion anomalies associated with MDD,
resulting from logistic regression with MDD as
dependent variable and all the possible risk factors
entered in a unique block
Possible Risk Factors P O.R CL 95%
HT 0.94 1.83 0.1 - > 100
SPECT diffuse hypoperfusion 0.05 3.34 3.0 - 3.8
SPECT Left Frontal hypoperfusion 0.01 9.82 1.7 - 55.7
SPECT Right Frontal hypoperfusion 0.82 0.83 0.16 - 4.2
SPECT Left Parietal hypoperfusion 0.85 0.00 -
SPECT Right Parietal hypoperfusion 0.15 4.58 0.1 - 10.2
SPECT Left Temporal hypoperfusion 0.05 5.23 1.0 - 26.9
SPECT Right Temporal hypoperfusion 0.78 0.71 0.1 - 7.2
SPECT Parietal Perfusion Asymmetry (PAI) 0.03 6.8 1.2 - 37.4
P values statistically significant at the 5% level are reported in bold.
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(21.9%) with HT and in 1 patient (4.5%) without HT.
Despite the high O.R (5.9) the difference in frequency
does not reach statistical significance (c
2 =2 . 0 ;P=
0.11) (see Table 4). However, within the sub-sample of
cases with HT the association between parietal perfusion
asymmetry and depression was statistically significant
(O.R = 13.1, c
2 = 6.2, P < 0.01) (see table 5) since such
an association was not found in subjects without HT
(Table 6).
Discussion
Our study indicates that the association between MDD
and HT (OR = 1.8) is not statistically significant. How-
ever, we point out that our sample size is small, and
that the control patients had chronic conditions such as
coeliac disease and endemic goitre, which have been
reported to increase the risk for MDD [27]. One of the
aims of the study was to identify specific pattern in
MDD associated with HT. However, the fact that the
frequency of MDD in the subgroup with HT is not very
different from the frequency of MDD in the sub group
without HT is only a partial answer given the sample
size.
On the other hand, our study indicates that MDD is
associated with asymmetry in cerebral diffuse hypoper-
fusion, right and left Frontal hypoperfusion, right Tem-
poral hypoperfusion and Parietal perfusion. Perfusion
anomalies observed in MDD are consistent with results
from previous studies [16]. However, left parietal asym-
metry is a new finding since it has never been described
to our knowledge in association with major depression.
Interestingly, this condition of parietal perfusion asym-
metry has been described in a study as a perfusion
anomalies in post-operative hypothyroidism [28]. More-
over, differential analysis of samples of patients with and
without HT, the parietal perfusion asymmetry seems to
be associated with MDD in a statistically significant way
only in HT compared to control.
Another interesting finding of our study is that left
temporal hypoperfusion was associated with MDD,
which is consistent with previous studies [16]. On the
other hand, the presence of HTd e c r e a s e dt h es i g n i f i -
cance of left temporal hypoperfusion on MDD. Consis-
tent with this finding, depression patients with HT did
not have any left temporal hypoperfusion.
Ultimately, MDD in HT patients appears to be charac-
terized by an absence of left temporal hypoperfusion
and by the presence of parietal perfusion asymmetry,
the latter is also typical of non-immune related
hypothyroidisms. The thyroiditis cases we studied here
were all in fact in euthyroidism condition. This suggests
that in the autoimmune thyroditis, a subclinical or slight
hypothyroiditis may have a role in MDD even when it is
not detectable with routine tests [27]. This can be
attributed to the vulnerability of neuronal cells. This
finding, if confirmed, would suggest that, although the
damage to cerebral vascularisation is associated with a
risk for depression, it could be related to thyroid hypo-
function as well.
The debate on the pathogenesis of depression in thyr-
oid autoimmunity involves two hypotheses, which might
not be mutually exclusive. In one hypothesis, it is sug-
gested that neuronal tissue is hypersensitive to hormo-
nal deficiencies and are more vulnerable to possible
subclinical hormonal deficiencies not detectable with
routine laboratory tests [27]. In the second hypothesis, a
possible pathogenic factor linked to inflammation is
postulated, consequent to cytokine activation or extra-
glandular lesions similar to vasculitis-induced effects
[29,30].
The presence of a specific pattern of vascular damage
in MDD and HT, with some similarity to the vascular
damage observed in autoimmune hypothyrodism, may
Table 4 Parietal perfusion asymmetry in subjects with
and without Hashimoto Thyroiditis
PAI + PAI -
HASHIMOTO THYROIDITIS
+
21.9%
(7)
78.1%
(25)
c
2 = 2.0; df = 1
Yates’ correction was
used
P = 0.11
O.R = 5.9
CL 95% = 0.7 - 70.8
HASHIMOTO THYROIDITIS
-
4.5%
(1)
95.5%
(21)
Table 5 Association between parietal perfusion
asymmetry and depression in patients with Hashimoto
Thyroiditis (HT+)
HT+ PAI+ HT+ PAI-
DEPRESSED 71.43%
(5)
16%
(4)
c
2 = 6.2; df = 1
P < 0.01
Yates’ correction was used
O.R = 13.1
CL 95% = 1.7 - 98.7
NOT-DEPRESSED 28.57%
(2)
84%
(21)
Table 6 Association between parietal perfusion
asymmetry and depression in patients without
Hashimoto Thyroiditis (HT-)
HT- PAI+ HT- PAI-
DEPRESSED 0%
(0)
23.80%
(5)
c
2 = 0.44; df = 1
Yates’ correction was used
P = 0.50
O.R = 0
NOT-DEPRESSED 100%
(1)
76.20%
(16)
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of MDD. Further studies should clarify whether perfu-
sion peculiarities are associated with particular syndro-
mic psychopathological features in MDD concomitant
with HT.
It has been recently underlined that thyroid autoim-
munity appears to be more frequent in atypical depres-
sions [29] and that these forms would present with
differentiated perfusion pictures compared to melan-
cholic depressions. Another notable point is that signifi-
cantly higher levels of thyroid microsomal antibodies
were found in patients with MDD and a family history
of dementia, compared with those who did not have
such family history [31]. This suggests a specific clinical
profile for the association between MDD and autoim-
mune thyroiditis. The relationship of these clinical pecu-
liarities and specific pattern of vascular damage in MDD
and HT need to be further ascertained.
Study limitations
Our results from this study require further confirmation
since the sample we studied, while balanced through mul-
tivariate analysis, was not initially selected to evaluate our
hypothesis and therefore does not have a control group of
MDD without any general medical conditions. However,
as previously described, coeliac disease presents a very
high risk for HT compared to individuals without thyroid
pathologies; thus having eliminated the possible confound-
ing effect due to this factor is not an unremarkable ele-
ment. Nonetheless, it is necessary to underline that this
study may be considered somewhat preliminary.
Another relevant point is that the small sample does
not allow us to consider other factors of possible rele-
vance such as 1) the ageing process. It is well known
that ageing causes loss of gray matter, and therefore a
secondary CBF and metabolism reduction in those same
areas can occur, 2) a possible difference in the perfusion
in active depressive picture and remitted depressive pic-
ture. The rCBF alterations in depression can partially
normalize as a response to treatment with medications,
interpersonal psychotherapy, or a placebo effect [14,17],
but a different pattern of perfusion changes is seen as a
response to venlafaxine [18] or cognitive behavioral
therapy [19]. Thus these variables need to be considered
in further studies. Nevertheless, considering the diffi-
culty and the human, ethical and monetary costs in car-
rying out studies with SPECT in patients not needing
such a test for clinical diagnosis, our preliminary study
should be considered important and a basis for future
“ad hoc” research.
Conclusions
This study suggests that in HT, but not in subjects with
coeliac disease and euthyroid goitre, the MDD is
characterized by temporal hypoperfusion and also by a
frequent parietal hypoperfusion asymmetry. Further stu-
dies should confirm these results and should clarify
whether perfusion peculiarities are associated with the
specific syndromic psychopathological features of thyroi-
ditis mood disorders described in the literature.
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